Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1987 Feb;79(2):547–556. doi: 10.1172/JCI112846

Hyperglucagonemia and insulin-mediated glucose metabolism.

S Del Prato, P Castellino, D C Simonson, R A DeFronzo
PMCID: PMC424124  PMID: 3543054

Abstract

The effect of chronic physiologic hyperglucagonemia on basal and insulin-mediated glucose metabolism was evaluated in normal subjects, using the euglycemic insulin clamp technique (+50, +100, and +500 microU/ml). After glucagon infusion fasting glucose increased from 76 +/- 4 to 93 +/- 2 mg/dl and hepatic glucose production (HGP) rose from 1.96 +/- 0.08 to 2.25 +/- 0.08 mg/kg X min (P less than 0.001). Basal glucose oxidation after glucagon increased (P less than 0.05) and correlated inversely with decreased free fatty acid concentrations (r = -0.94; P less than 0.01) and decreased lipid oxidation (r = -0.75; P less than 0.01). Suppression of HGP and stimulation of total glucose disposal were impaired at each insulin step after glucagon (P less than 0.05-0.01). The reduction in insulin-mediated glucose uptake was entirely due to diminished non-oxidative glucose utilization. Glucagon infusion also caused a decrease in basal lipid oxidation and an enhanced ability of insulin to inhibit lipid oxidation and augment lipid synthesis. These results suggest that hyperglucagonemia may contribute to the disturbances in glucose and lipid metabolism in some diabetic patients.

Full text

PDF
547

Images in this article

549Image
on p.549
549Image
on p.549
550Image
on p.550
550Image
on p.550
551Image
on p.551

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acheson K. J., Schutz Y., Bessard T., Ravussin E., Jéquier E., Flatt J. P. Nutritional influences on lipogenesis and thermogenesis after a carbohydrate meal. Am J Physiol. 1984 Jan;246(1 Pt 1):E62–E70. doi: 10.1152/ajpendo.1984.246.1.E62. [DOI] [PubMed] [Google Scholar]
  2. Björntorp P., Sjöström L. Carbohydrate storage in man: speculations and some quantitative considerations. Metabolism. 1978 Dec;27(12 Suppl 2):1853–1865. doi: 10.1016/s0026-0495(78)80004-3. [DOI] [PubMed] [Google Scholar]
  3. Boden G., Wilson R. M., Owen O. E. Effects of chronic glucagon excess on hepatic metabolism. Diabetes. 1978 Jun;27(6):643–648. doi: 10.2337/diab.27.6.643. [DOI] [PubMed] [Google Scholar]
  4. Bomboy J. D., Jr, Lewis S. B., Lacy W. W., Sinclair-Smith B. C., Liljenquist J. E. Transient stimulatory effect of sustained hyperglucagonemia on splanchnic glucose production in normal and diabetic man. Diabetes. 1977 Mar;26(3):177–174. doi: 10.2337/diab.26.3.177. [DOI] [PubMed] [Google Scholar]
  5. Bomboy J. D., Jr, Lewis S. B., Lacy W. W., Sinclair-Smith B. C., Liljenquist J. E. Transient stimulatory effect of sustained hyperglucagonemia on splanchnic glucose production in normal and diabetic man. Diabetes. 1977 Mar;26(3):177–174. doi: 10.2337/diab.26.3.177. [DOI] [PubMed] [Google Scholar]
  6. Boyd M. E., Albright E. B., Foster D. W., McGarry J. D. In vitro reversal of the fasting state of liver metabolism in the rat. Reevaluation of the roles of insulin and glucose. J Clin Invest. 1981 Jul;68(1):142–152. doi: 10.1172/JCI110230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bratusch-Marrain P. R., Smith D., DeFronzo R. A. The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab. 1982 Nov;55(5):973–982. doi: 10.1210/jcem-55-5-973. [DOI] [PubMed] [Google Scholar]
  8. Cherrington A. D., Vranic M. Effect of interaction between insulin and glucagon on glucose turnover and FFA concentration in normal and depancreatized dogs. Metabolism. 1974 Aug;23(8):729–744. doi: 10.1016/0026-0495(74)90005-5. [DOI] [PubMed] [Google Scholar]
  9. Cherrington A. D., Williams P. E., Shulman G. I., Lacy W. W. Differential time course of glucagon's effect on glycogenolysis and gluconeogenesis in the conscious dog. Diabetes. 1981 Mar;30(3):180–187. doi: 10.2337/diab.30.3.180. [DOI] [PubMed] [Google Scholar]
  10. Chiasson J. L., Liljenquist J. E., Finger F. E., Lacy W. W. Differential sensitivity of glycogenolysis and gluconeogenesis to insulin infusions in dogs. Diabetes. 1976 Apr;25(4):283–291. doi: 10.2337/diab.25.4.283. [DOI] [PubMed] [Google Scholar]
  11. Cowan J. S., Hetenyi G., Jr Glucoregulatory responses in normal and diabetic dogs recorded by a new tracer method. Metabolism. 1971 Apr;20(4):360–372. doi: 10.1016/0026-0495(71)90098-9. [DOI] [PubMed] [Google Scholar]
  12. Creutzfeldt W., Frerichs H., Sickinger K. Liver diseases and diabetes mellitus. Prog Liver Dis. 1970;3:371–407. [PubMed] [Google Scholar]
  13. DeFronzo R. A., Ferrannini E., Hendler R., Felig P., Wahren J. Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes. 1983 Jan;32(1):35–45. doi: 10.2337/diab.32.1.35. [DOI] [PubMed] [Google Scholar]
  14. DeFronzo R. A., Ferrannini E., Hendler R., Wahren J., Felig P. Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange. Proc Natl Acad Sci U S A. 1978 Oct;75(10):5173–5177. doi: 10.1073/pnas.75.10.5173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. DeFronzo R. A., Ferrannini E., Koivisto V. New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus. Am J Med. 1983 Jan 17;74(1A):52–81. doi: 10.1016/0002-9343(83)90654-x. [DOI] [PubMed] [Google Scholar]
  16. DeFronzo R. A., Hendler R., Simonson D. Insulin resistance is a prominent feature of insulin-dependent diabetes. Diabetes. 1982 Sep;31(9):795–801. doi: 10.2337/diab.31.9.795. [DOI] [PubMed] [Google Scholar]
  17. DeFronzo R. A., Jacot E., Jequier E., Maeder E., Wahren J., Felber J. P. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes. 1981 Dec;30(12):1000–1007. doi: 10.2337/diab.30.12.1000. [DOI] [PubMed] [Google Scholar]
  18. DeFronzo R. A., Simonson D., Ferrannini E. Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1982 Oct;23(4):313–319. doi: 10.1007/BF00253736. [DOI] [PubMed] [Google Scholar]
  19. DeFronzo R. A., Soman V., Sherwin R. S., Hendler R., Felig P. Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding. J Clin Invest. 1978 Jul;62(1):204–213. doi: 10.1172/JCI109108. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  20. DeFronzo R. A., Tobin J. D., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979 Sep;237(3):E214–E223. doi: 10.1152/ajpendo.1979.237.3.E214. [DOI] [PubMed] [Google Scholar]
  21. DeFronzo R., Deibert D., Hendler R., Felig P., Soman V. Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes. J Clin Invest. 1979 May;63(5):939–946. doi: 10.1172/JCI109394. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  22. Deibert D. C., DeFronzo R. A. Epinephrine-induced insulin resistance in man. J Clin Invest. 1980 Mar;65(3):717–721. doi: 10.1172/JCI109718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Del Prato S., Nosadini R., Tiengo A., Tessari P., Avogaro A., Trevisan R., Valerio A., Muggeo M., Cobelli C., Toffolo G. Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance. J Clin Endocrinol Metab. 1983 Nov;57(5):904–910. doi: 10.1210/jcem-57-5-904. [DOI] [PubMed] [Google Scholar]
  24. Del Prato S., Tiengo A., Baccaglini U., Tremolada C., Duner E., Marescotti M. C., Avogaro A., Valverde I., Nosadini R., Assan R. Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy. Diabetologia. 1983 Sep;25(3):252–259. doi: 10.1007/BF00279939. [DOI] [PubMed] [Google Scholar]
  25. Felig P., Wahren J., Hendler R. Influence of physiologic hyperglucagonemia on basal and insulin-inhibited splanchnic glucose output in normal man. J Clin Invest. 1976 Sep;58(3):761–765. doi: 10.1172/JCI108523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ferrannini E., Barrett E. J., Bevilacqua S., DeFronzo R. A. Effect of fatty acids on glucose production and utilization in man. J Clin Invest. 1983 Nov;72(5):1737–1747. doi: 10.1172/JCI111133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ferrannini E., DeFronzo R. A., Sherwin R. S. Transient hepatic response to glucagon in man: role of insulin and hyperglycemia. Am J Physiol. 1982 Feb;242(2):E73–E81. doi: 10.1152/ajpendo.1982.242.2.E73. [DOI] [PubMed] [Google Scholar]
  28. Frayn K. N. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol Respir Environ Exerc Physiol. 1983 Aug;55(2):628–634. doi: 10.1152/jappl.1983.55.2.628. [DOI] [PubMed] [Google Scholar]
  29. GOODMAN J. I. Hepatomegaly and diabetes mellitus. Ann Intern Med. 1953 Nov;39(5):1077–1087. doi: 10.7326/0003-4819-39-5-1077. [DOI] [PubMed] [Google Scholar]
  30. Gerich J. E., Lorenzi M., Bier D. M., Schneider V., Tsalikian E., Karam J. H., Forsham P. H. Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon. N Engl J Med. 1975 May 8;292(19):985–989. doi: 10.1056/NEJM197505082921901. [DOI] [PubMed] [Google Scholar]
  31. Gerich J. E., Lorenzi M., Schneider V., Karam J. H., Rivier J., Guillemin R., Forsham P. H. Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications. N Engl J Med. 1974 Sep 12;291(11):544–547. doi: 10.1056/NEJM197409122911102. [DOI] [PubMed] [Google Scholar]
  32. Ginsberg H. N. Investigation of insulin sensitivity in treated subjects with ketosis-prone diabetes mellitus. Diabetes. 1977 Apr;26(4):278–283. doi: 10.2337/diab.26.4.278. [DOI] [PubMed] [Google Scholar]
  33. Ginsberg H., Kimmerling G., Olefsky J. M., Reaven G. M. Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia. J Clin Invest. 1975 Mar;55(3):454–461. doi: 10.1172/JCI107951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Gruppuso P. A., Susa J. B., Domenech M., Cha C. J., Schwartz R. Chronic hyperglucagonemia in rats: effects on insulin, substrates, and hepatic enzymes of intermediary metabolism. Metabolism. 1983 Sep;32(9):911–918. doi: 10.1016/0026-0495(83)90206-8. [DOI] [PubMed] [Google Scholar]
  35. Gómez F., Jéquier E., Chabot V., Büber V., Felber J. P. Carbohydrate and lipid oxidation in normal human subjects: its influence on glucose tolerance and insulin response to glucose. Metabolism. 1972 May;21(5):381–391. doi: 10.1016/0026-0495(72)90051-0. [DOI] [PubMed] [Google Scholar]
  36. Herbert V., Lau K. S., Gottlieb C. W., Bleicher S. J. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab. 1965 Oct;25(10):1375–1384. doi: 10.1210/jcem-25-10-1375. [DOI] [PubMed] [Google Scholar]
  37. Kahn C. R. Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction. Metabolism. 1978 Dec;27(12 Suppl 2):1893–1902. doi: 10.1016/s0026-0495(78)80007-9. [DOI] [PubMed] [Google Scholar]
  38. Lins P. E., Wajngot A., Adamson U., Vranic M., Efendić S. Minimal increases in glucagon levels enhance glucose production in man with partial hypoinsulinemia. Diabetes. 1983 Jul;32(7):633–636. doi: 10.2337/diab.32.7.633. [DOI] [PubMed] [Google Scholar]
  39. McGarry J., Wright P. H., Foster D. W. Hormonal control of ketogenesis. Rapid activation of hepatic ketogenic capacity in fed rats by anti-insulin serum and glucagon. J Clin Invest. 1975 Jun;55(6):1202–1209. doi: 10.1172/JCI108038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Muggeo M., Saviolakis A., Wachslicht-Rodbard H., Roth J. Effects of chronic glucocorticoid excess in man on insulin binding to circulating cells: differences between endogenous and exogenous hypercorticism. J Clin Endocrinol Metab. 1983 Jun;56(6):1169–1177. doi: 10.1210/jcem-56-6-1169. [DOI] [PubMed] [Google Scholar]
  41. NOVAK M. COLORIMETRIC ULTRAMICRO METHOD FOR THE DETERMINATION OF FREE FATTY ACIDS. J Lipid Res. 1965 Jul;6:431–433. [PubMed] [Google Scholar]
  42. Nankervis A., Proietto J., Aitken P., Alford F. Impaired insulin action in newly diagnosed type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1984 Nov;27(5):497–503. doi: 10.1007/BF00290383. [DOI] [PubMed] [Google Scholar]
  43. Newgard C. B., Hirsch L. J., Foster D. W., McGarry J. D. Studies on the mechanism by which exogenous glucose is converted into liver glycogen in the rat. A direct or an indirect pathway? J Biol Chem. 1983 Jul 10;258(13):8046–8052. [PubMed] [Google Scholar]
  44. Nosadini R., Del Prato S., Tiengo A., Valerio A., Muggeo M., Opocher G., Mantero F., Duner E., Marescotti C., Mollo F. Insulin resistance in Cushing's syndrome. J Clin Endocrinol Metab. 1983 Sep;57(3):529–536. doi: 10.1210/jcem-57-3-529. [DOI] [PubMed] [Google Scholar]
  45. Nosadini R., del Prato S., Tiengo A., Duner E., Toffolo G., Cobelli C., Faronato P. P., Moghetti P., Muggeo M. Insulin sensitivity, binding, and kinetics in pancreatogenic and type I diabetes. Diabetes. 1982 Apr;31(4 Pt 1):346–355. doi: 10.2337/diab.31.4.346. [DOI] [PubMed] [Google Scholar]
  46. Olefsky J. M., Kolterman O. G. Mechanisms of insulin resistance in obesity and noninsulin-dependent (type II) diabetes. Am J Med. 1981 Jan;70(1):151–168. doi: 10.1016/0002-9343(81)90422-8. [DOI] [PubMed] [Google Scholar]
  47. Pernet A., Trimble E. R., Kuntschen F., Damoiseaux P., Assal J. P., Hahn C., Renold A. E. Insulin resistance in Type 1 (insulin-dependent) diabetes: dependence on plasma insulin concentration. Diabetologia. 1984 Apr;26(4):255–260. doi: 10.1007/BF00283646. [DOI] [PubMed] [Google Scholar]
  48. Pozefsky T., Tancredi R. G., Moxley R. T., Dupre J., Tobin J. D. Metabolism of forearm tissues in man. Studies with glucagon. Diabetes. 1976 Feb;25(2):128–135. doi: 10.2337/diab.25.2.128. [DOI] [PubMed] [Google Scholar]
  49. RANDLE P. J., GARLAND P. B., HALES C. N., NEWSHOLME E. A. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963 Apr 13;1(7285):785–789. doi: 10.1016/s0140-6736(63)91500-9. [DOI] [PubMed] [Google Scholar]
  50. Radziuk J., Norwich K. H., Vranic M. Measurement and validation of nonsteady turnover rates with applications to the inulin and glucose systems. Fed Proc. 1974 Jul;33(7):1855–1864. [PubMed] [Google Scholar]
  51. Reaven G. M., Bernstein R., Davis B., Olefsky J. M. Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? Am J Med. 1976 Jan;60(1):80–88. doi: 10.1016/0002-9343(76)90536-2. [DOI] [PubMed] [Google Scholar]
  52. Rizza R. A., Gerich J. E. Persistent effect of sustained hyperglucagonemia on glucose production in man. J Clin Endocrinol Metab. 1979 Feb;48(2):352–355. doi: 10.1210/jcem-48-2-352. [DOI] [PubMed] [Google Scholar]
  53. Rizza R. A., Mandarino L. J., Genest J., Baker B. A., Gerich J. E. Production of insulin resistance by hyperinsulinaemia in man. Diabetologia. 1985 Feb;28(2):70–75. doi: 10.1007/BF00279918. [DOI] [PubMed] [Google Scholar]
  54. Rizza R. A., Mandarino L. J., Gerich J. E. Mechanism and significance of insulin resistance in non-insulin-dependent diabetes mellitus. Diabetes. 1981 Dec;30(12):990–995. doi: 10.2337/diab.30.12.990. [DOI] [PubMed] [Google Scholar]
  55. Rizza R., Verdonk C., Miles J., Service F. J., Gerich J. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man. J Clin Invest. 1979 Jun;63(6):1119–1123. doi: 10.1172/JCI109404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. STEELE R. Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci. 1959 Sep 25;82:420–430. doi: 10.1111/j.1749-6632.1959.tb44923.x. [DOI] [PubMed] [Google Scholar]
  57. Sacca L., Hendler R., Sherwin R. S. Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones. J Clin Endocrinol Metab. 1978 Nov;47(5):1160–1163. doi: 10.1210/jcem-47-5-1160. [DOI] [PubMed] [Google Scholar]
  58. Schneider S. H., Fineberg S. E., Blackburn G. L. The acute metabolic effects of glucagon and its interactions with insulin in forearm tissue. Diabetologia. 1981 Jun;20(6):616–621. doi: 10.1007/BF00257430. [DOI] [PubMed] [Google Scholar]
  59. Shulman G. I., Williams P. E., Liljenquist J. E., Lacy W. W., Keller U., Cherrington A. D. Effect of hyperglycemia independent of changes in insulin or glucagon on lipolysis in the conscious dog. Metabolism. 1980 Apr;29(4):317–320. doi: 10.1016/0026-0495(80)90004-9. [DOI] [PubMed] [Google Scholar]
  60. Steiner K. E., Mouton S. M., Bowles C. R., Williams P. E., Cherrington A. D. The relative importance of first- and second-phase insulin secretion in countering the action of glucagon on glucose turnover in the conscious dog. Diabetes. 1982 Nov;31(11):964–972. doi: 10.2337/diacare.31.11.964. [DOI] [PubMed] [Google Scholar]
  61. Thiébaud D., DeFronzo R. A., Jacot E., Golay A., Acheson K., Maeder E., Jéquier E., Felber J. P. Effect of long chain triglyceride infusion on glucose metabolism in man. Metabolism. 1982 Nov;31(11):1128–1136. doi: 10.1016/0026-0495(82)90163-9. [DOI] [PubMed] [Google Scholar]
  62. Tiengo A., Bessioud M., Valverde I., Tabbi-Anneni A., Delprato S., Alexandre J., Assan R. Absence of islet alpha cell function in pancreatectomized patients. Diabetologia. 1982 Jan;22(1):25–32. doi: 10.1007/BF00253865. [DOI] [PubMed] [Google Scholar]
  63. Trimble E. R., Weir G. C., Gjinovci A., Assimacopoulos-Jeannet F., Benzi R., Renold A. E. Increased insulin responsiveness in vivo and in vitro consequent to induced hyperinsulinemia in the rat. Diabetes. 1984 May;33(5):444–449. doi: 10.2337/diab.33.5.444. [DOI] [PubMed] [Google Scholar]
  64. Unger R. H., Orci L. The essential role of glucagon in the pathogenesis of diabetes mellitus. Lancet. 1975 Jan 4;1(7897):14–16. doi: 10.1016/s0140-6736(75)92375-2. [DOI] [PubMed] [Google Scholar]
  65. Unger R. H. Role of glucagon in the pathogenesis of diabetes: the status of the controversy. Metabolism. 1978 Nov;27(11):1691–1709. doi: 10.1016/0026-0495(78)90291-3. [DOI] [PubMed] [Google Scholar]
  66. Ward W. K., Best J. D., Halter J. B., Porte D., Jr Prolonged infusion of somatostatin with glucagon replacement increases plasma glucose and glucose turnover in man. J Clin Endocrinol Metab. 1984 Mar;58(3):449–453. doi: 10.1210/jcem-58-3-449. [DOI] [PubMed] [Google Scholar]
  67. Wardzala L. J., Hirshman M., Pofcher E., Horton E. D., Mead P. M., Cushman S. W., Horton E. S. Regulation of glucose utilization in adipose cells and muscle after long-term experimental hyperinsulinemia in rats. J Clin Invest. 1985 Aug;76(2):460–469. doi: 10.1172/JCI111994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Whitty A. J., Shima K., Trubow M., Foà P. P. Effect of glucagon and of insulin on serum free fatty acids in normal and depancreatized dogs. Proc Soc Exp Biol Med. 1969 Jan;130(1):55–61. doi: 10.3181/00379727-130-33487. [DOI] [PubMed] [Google Scholar]
  69. Yasuda H., Harano Y., Ohgaku S., Kosugi K., Suzuki M., Hidaka H., Kashiwagi A., Shigeta Y. Insulin sensitivity in pancreatitis, liver diseases, steroid treatment and hyperthyroidism assessed by glucose, insulin and somatostatin infusion. Horm Metab Res. 1984 Jan;16(1):3–6. doi: 10.1055/s-2007-1014681. [DOI] [PubMed] [Google Scholar]
  70. Yki-Järvinen H., Koivisto V. A. Insulin sensitivity in newly diagnosed type 1 diabetics after ketoacidosis and after three months of insulin therapy. J Clin Endocrinol Metab. 1984 Sep;59(3):371–378. doi: 10.1210/jcem-59-3-371. [DOI] [PubMed] [Google Scholar]
  71. Yki-Järvinen H., Taskinen M. R., Kiviluoto T., Hilden H., Helve E., Koivisto V. A., Nikkilä E. A. Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro. J Clin Endocrinol Metab. 1984 Dec;59(6):1183–1192. doi: 10.1210/jcem-59-6-1183. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES